Coty Inc. Files 2024 10-K Report

Ticker: COTY · Form: 10-K · Filed: 2024-08-20T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, annual-report, cosmetics

TL;DR

COTY filed its 2024 10-K. Full financials and biz details out now.

AI Summary

Coty Inc. filed its 2024 10-K report, detailing its fiscal year ending June 30, 2024. The company, headquartered at 350 Fifth Avenue, New York, NY, operates in the perfumes and cosmetics industry. The filing covers financial performance and business operations for the period, with specific financial data and disclosures expected to be detailed within the full report.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Coty Inc.'s financial health and strategic direction for the fiscal year 2024, enabling informed investment decisions.

Risk Assessment

Risk Level: medium — Annual 10-K filings inherently carry medium risk due to the comprehensive financial and operational data they contain, which can reveal significant company performance and future outlook.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Coty Inc. as indicated in the filing?

Coty Inc. is primarily involved in the 'PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS' industry, as indicated by its Standard Industrial Classification code [2844].

What is the SEC file number for Coty Inc.'s 10-K filing?

The SEC file number for this 10-K filing is 001-35964.

When was the 10-K report for Coty Inc. filed?

The 10-K report was filed on August 20, 2024.

What is the central index key (CIK) for Coty Inc.?

The Central Index Key (CIK) for Coty Inc. is 0001024305.

What is the fiscal year end date for Coty Inc.?

Coty Inc.'s fiscal year end is June 30.

Filing Stats: 4,349 words · 17 min read · ~14 pages · Grade level 20 · Accepted 2024-08-20 16:40:47

Key Financial Figures

Filing Documents

Business

Business 1 Item 1A.

Risk Factors

Risk Factors 7 Item 1B. Unresolved Staff Comments 28 Item 1C. Cybersecurity 28 Item 2.

Properties

Properties 29 Item 3.

Legal Proceedings

Legal Proceedings 29 Part II: Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 33 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 62 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 62 Item 9A.

Controls and Procedures

Controls and Procedures 62 Item 9B. Other Information 62 Part III: Item 10. Directors, Executive Officers and Corporate Governance 63 Item 11.

Executive Compensation

Executive Compensation 63 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 63 Item 13. Certain Relationships and Related Transactions, and Director Independence 63 Item 14. Principal Accounting Fees and Services 63 Part IV: Item 15. Exhibits, Financial Statement Schedules 63

Signatures

Signatures 71

Forward-looking Statements

Forward-looking Statements Certain statements in this Form 10-K are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"), Section 27A of the Securities Act of 1933, as amended ("Securities Act"), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, strategic planning, targets and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), the Company's future operations and strategy (including the expected implementation and related impact of its strategic priorities), ongoing and future cost efficiency, optimization and restructuring initiatives and programs, expectations of the impact of inflationary pressures and the timing, magnitude and impact of pricing actions to offset inflationary costs, strategic transactions (including their expected timing and impact), expectations and/or plans with respect to joint ventures (including Wella and the timing and size of any related divestiture, distribution or return of capital), the Company's capital allocation strategy and payment of dividends (including suspension of dividend payments and the duration thereof and any plans to resume cash dividends on common stock or to continue to pay dividends in cash on preferred stock) and expectations for stock repurchases, investments, licenses and portfolio changes, product launches, relaunches or rebranding (including the expected timing or impact thereof), synergies, savings, performance, cost, timing and integration of acquisitions, future cash flows, liquidity and borrowing capacity (including any refinancing or deleveraging activities), timing and size of cash outflows and debt deleveraging, the timing and extent of any future impairments, and synerg

Business

Item 1. Business. Overview F

View on Read The Filing